Navigation Links
Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit
Date:12/2/2009

SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through extraordinary times; markets are in turmoil and uncertainty is part of many businesses and industries. It turns out that the pharma industry has been relatively immune to the economic downturn, because illness doesn't take a vacation.

During the midst of the difficult times this year, the pharmaceutical giant Johnson & Johnson inaugurated an R&D center in Shanghai, the largest of its kind in Asia. A similar plan was laid down by its biotech counterpart Genzyme, who invested USD90 million in Beijing to construct the company's first ever research facility in Asia.

What has made pharma and biotech companies invest heavily in Asia?

Find out the answer at Asia Pharma R&D Leaders 2010. As the time is drawing near for the event, the world's industry leaders will be under one roof to provide solutions and case studies in the challenging areas of drug research and development.

This year's meeting will aim to improve understanding of how the Asian pharmaceutical market is changing. Meet with key pharma industry leaders to discuss and learn from their own experiences and hear from real-life case studies on operational, regulatory, and strategic challenges of outsourcing drug discovery work to Asia. This event also provides excellent networking opportunities by way of a speed networking sessions where attendees will exchange details and make new contacts, as well as our contact system, which will allow participants to arrange meetings and email conference with attendees, speakers and the press.

    An updated list of this year's highlighted topics:
    -- Partnering for innovation in Asia, new collaboration opportunities with
       big pharma
       Laurent Bertin, Vice President, R&D External Innovation, Sanofi-Aventis
       Hans-Jochiam Bohm, Head of Global Chemistry, Hoffman La-Roche
       Daniel Grant, Head of Strategic Alliances, Pfizer Australia
       Pierre Desmons, Director, Head of Development Partnerships,
        GlaxoSmithKline Biologicals
    -- Regulatory updates in China and how the FDA is verifying the quality
       of outsourced work
       Christopher Hickey, Country Director (China), U.S. Food and Drug
        Administration
    -- Successful stories of R&D operation management in Asia and Do's &
       Don'ts in outsourcing
       Steve Yang, Head of Research Asia Global R&D, Pfizer
       Lily Lee, Senior Vice President and Head of Pharmaceutical R&D Asia,
        Johnson & Johnson
       Li Chen, Chief Scientific Officer Roche R&D China, Roche
       Tony Zhang, Managing Director and Site Head of China, Eli Lilly Global
        R&D
       Canwen Jiang, Head of R&D Asia, Genzyme Corporation
       Kim Andersen, Vice President R&D, Lundbeck AS
       Samantha Du, CEO, Hutchison MediPharma
       Richard Wang, Director, Strategic Alliance and Collaboration for Asia,
        AstraZeneca
       Yoshiki Nishikawa, Director of Kobe Pharma Research Institute Nippon,
        Boehringer Ingelheim

Plus, the event sets up an effective platform for attendees to meet face to face with a variety of Asia's local CROs and leading clinical practitioners to discuss the specifics of outsourcing requirements.

An international audience consisting of senior-level pharma and biotech executives from the R&D, clinical development, business development, global market access, licensing, and regulatory affairs functions will be in attendance. For the full program and list of companies scheduled to attend, please visit the event website at http://www.aprdl.com.


    For more information on registration and sponsoring/exhibiting, please
contact:

     Daniel Chen
     Global Leaders Institute
     Phone: +86-21-3251-6046
     Email: daniel.chen@globaleaders.com

SOURCE Global Leaders Institute


'/>"/>
SOURCE Global Leaders Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million
2. Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service
3. Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services
4. Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM)
5. China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List
6. WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year
7. Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance
8. KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals
9. Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference
10. PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend
11. NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
(Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):